Mode
Text Size
Log in / Sign up
N/A N=50 Randomized Supportive Care

Problem Solving Skills Training in Adult Cancer Survivors: Bright IDEAS-AC

Colo-rectal Cancer

Enrolled (actual)
50
Serious AEs
0.0%
Results posted
Sep 2022
Primary outcome: Primary: Mean Physical Health of Patient at Enrollment — 77.2; 82.7 score on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Problem solving Skills Training (Behavioral)
Age
Adult, Older Adult · 21+ yrs
Sex
All
Sponsor
Roswell Park Cancer Institute
Primary completion
Mar 2021

Outcome Measures

OutcomeResultp-value
PRIMARY
Mean Physical Health of Patient at Enrollment
77.2; 82.7
PRIMARY
Behavioral Health of Patient
12.2; 11.7
PRIMARY
Mean Change in Physical Health From Baseline to 3-months
77.2; 82.7; 82.4; 82.4
PRIMARY
Mean Change Physical Health of Patient at 12 Months
77.2; 82.7; 87.1; 82.3
PRIMARY
Mean Change in Behavioral Health of Patient at 3 Months
12.2; 11.7; 13.4; 11.6
PRIMARY
Mean Change in Behavioral Health of Patient at 12 Months
12.2; 11.7; 13.8; 11.7
PRIMARY
Healthcare Utilization of Patients
0.0; 0.4; 0.0; 0.3; 6.5; 5.7

Summary

The aim of this 2-year study will assess the acceptability and feasibility of offering Problem Solving Skills Therapy (PSST) to cancer survivors and their caregivers focusing on the highest risk patients with distress.

Eligibility Criteria

Inclusion Criteria

  • stage I-III Colorectal Cancer, Breast, Bladder or Prostate Cancer
  • meet the screening criteria for psychological distress (NCCN Distress >2)
  • be able to speak English
  • have a 5-year survival rate of 50% or greater as deemed by their oncologist, surgeon,or other relevant attending physician (suggesting a reasonable rate of cure or prolonged medical survival with state-of-the-art medical care)
  • be willing to provide written informed consent to participate in the study which includes several clinical evaluations, provide access to medical records/PCP, and allow all interviews and PSST therapy sessions to be audiotaped.
  • Among patients treated in the urban centers, we will specifically target patients who live more than 40 miles away from the clinic as they are more likely to experience problems with access to care.
  • Age 21 or older

Exclusion Criteria

  • a diagnosis of mental retardation,
  • and/or acute suicidal behavior
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03567850). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search